Our Achievements

We own a track record of growing at an exponential pace since our inception. From 22 Million USD in 2005 to achieving about 750 Million USD turnover in FY 2022-23 and counting, we continue to expand our growth and global footprint by creating innovative solutions for tomorrow's healthcare requirements.

  • 500
  • 420
  • 350
  • 280
  • 210
  • 140
  • 70
  • 0
  • 2004
  • 2005
  • 2006
  • 2007
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
  • 2019

MSN group revenue growth (USD million)

Accreditations

  • ISO 9001: 2008 (< 20 months of inception)
  • WHO:GMP (< 24 months of inception)
  • EUGMP (< 48 months of inception)
  • USFDA (< 52 months of inception)
  • Hamburg, Germany
  • DSIR Recognition
  • Korean FDA
  • COFEPRIS
  • Department of Science & Technology, Govt. of India
  • Department of Scientific and Industrial Research, Govt. of India
  • TFDA
  • Kenya MOH approved
  • Invima

We own a track record of growing at an exponential pace since our inception.

Filings

  • 455 US / 138 EU / 121 CEP / 82 Korean / 46 Russia / 96 Canadian / 67 Taiwan / 13 Japanese / 67 China DMFs
  • 2400+ dossiers
  • 30+ first-to-launch generics
  • 900+ Indian & International Patents filed - 150+ granted

Recognitions & Awards

  • MSN Laboratories Wins Telangana State IP Award (TSIPA) in 2021
  • MSN Laboratories Limited has been awarded Packaging Team of the Year at the 6th edition of India Packaging Awards instituted by Informa Markets.
  • MSN Laboratories Wins National Intellectual Property(IP) Award 2016.
  • MSN Laboratories Wins Pharmaexcil’s Patent Award 2015
  • MSN Laboratories has been awarded TV5 Business Leader award 2015 in the Pharmaceutical (Medium Scale) category.
  • MSN Laboratories Limited has been awarded CPhI India Award 2012 for "Innovation in Cost". It recognizes our contribution (1st-in-India generics of Bosentan, Lacosamide, Silodosin, etc. at very affordable prices) to Healthcare in India.
  • Nominated as the Best Company in an Emerging Markets by Scrip Awards 2011
  • PHARMEXCIL (Pharmaceutical Export Promotion Council) Outstanding Export Performer Award, 2009 & 2010
  • FAPCCI Outstanding Export Performance Award in 2010
  • ICICI-CNBC TV18-CRISIL Emerging India Award 2010 for pioneering 'systems focus' in the pharmaceutical sector.
  • FAPCCI Excellence in R&D Award in 2008.
  • Udyog Ratan Award.
  • MSN has won the Customer Centric Business Partner Award from Abbott Healthcare Pvt. Ltd. for the year 2012.
  • MSN Laboratories has been awarded as a Healthy Workplaces-2023 by the Arogya World India Trust in partnership with the Public Health Foundation of India.

Our ever-growing portfolio

We are extremely grateful for the wonderful family of clients and customers that we have built across the globe.

Our Story

Quick Links

Our Contact

© MSN Laboratories | All right reserved.